LASER PLACEMENT IN NONCONTACT ND-YAG CYCLOPHOTOCOAGULATION

被引:13
作者
CRYMES, BM [1 ]
GROSS, RL [1 ]
机构
[1] BAYLOR UNIV,CULLEN EYE INST,6501 FANNIN,NC200,HOUSTON,TX 77030
关键词
D O I
10.1016/S0002-9394(14)77066-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We treated 40 eyes of 40 patients by using noncontact transscleral Nd:YAG cyclophotocoagulation to determine whether treatment 1.5 or 3.0 mm posterior to the corneoscleral limbus was preferable. Patients were randomly assigned to one of the treatment groups, and all other variables, including power, number, and distribution of laser applications, were kept constant. Six months postoperatively, those treated 1.5 mm posterior to the corneoscleral limbus had a lower intraocular pressure (P = .0047) than those treated 3.0 mm from the corneoscleral limbus. The 1.5-mm group also required fewer retreatments (P = .017) and had a slightly lower occurrence of visual acuity loss after this procedure. We believe it may be advantageous to locate the laser application approximately 1.5 mm posterior to the corneoscleral limbus, rather than further posteriorly, when performing noncontact transscleral Nd:YAG cyclophotocoagulation.
引用
收藏
页码:670 / 673
页数:4
相关论文
共 13 条
[1]  
BECKMAN H, 1973, ARCH OPHTHALMOL-CHIC, V90, P27
[2]  
BECKMAN H, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P423
[3]  
BECKMAN H, 1984, LASER THERAPY GLAUCO, P117
[4]  
BLASINI M, 1990, INVEST OPHTHALMOL VI, V31, P6
[5]  
DEVENYI RG, 1987, OPHTHALMOLOGY, V94, P1519
[6]  
FANKHAUSER F, 1986, OPHTHALMIC SURG LAS, V17, P94
[7]  
GROSS RL, 1986, INVEST OPHTHALMOL S, P253
[8]   TRANSSCLERAL NEODYMIUM-YAG CYCLOPHOTOCOAGULATION - A HISTOLOGIC-STUDY OF HUMAN AUTOPSY EYES [J].
HAMPTON, C ;
SHIELDS, MB .
ARCHIVES OF OPHTHALMOLOGY, 1988, 106 (08) :1121-1123
[9]  
KLAPPER RM, 1988, OPHTHALMOLOGY, V95, P719
[10]  
SCHUBERT HD, 1989, INVEST OPHTHALMOL VI, V30, P3